Over 1.5 million people have already been vaccinated with Sputnik V as part of the mass scale vaccination in Russia. Watch this video to find out how Sputnik V works and why it’s effective. | Sputnik V

Sputnik V is the world’s first registered human adenovirus vector-based COVID-19 vaccine developed by the Gamaleya Center in Russia. The human adenovirus vector platform has been studied over the decades and proven to be safe. Sign up for updates at sputnikvaccine.com | Sputnik V

'Sputnik V very efficient against virus strains, the skepticism about Sputnik V is gone', says Kirill Dmitriev, CEO of Russian Direct Investment Fund, on the partnership with an India-based drugmaker for production of 200 million doses of the two-dose jab. | NDTV